Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma lipoxin A4
and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 56, Issue 8, Pages 1977-1983
Publisher
Wiley
Online
2017-02-20
DOI
10.1002/mc.22629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance
- (2016) R. Poorani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lipoxin A4selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression
- (2016) R. L. Simões et al. INTERNATIONAL JOURNAL OF CANCER
- Lipoxin A4Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer
- (2016) Liang Zong et al. Oxidative Medicine and Cellular Longevity
- Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
- (2015) Jesmond Dalli et al. NATURE MEDICINE
- Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity
- (2015) HAOYU KUANG et al. ONCOLOGY REPORTS
- The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
- (2015) Charles N. Serhan et al. SEMINARS IN IMMUNOLOGY
- Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells
- (2015) Alexandru Marginean et al. Translational Research
- Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production
- (2015) Ramesh C. Halder et al. Frontiers in Physiology
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Lipoxin A4 Suppresses Lipopolysaccharide-Induced Hela Cell Proliferation and Migration via NF-κB Pathway
- (2014) Hua Hao et al. INFLAMMATION
- Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32
- (2013) Hye Ja Lee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation
- (2012) Antonio Recchiuti et al. Frontiers in Immunology
- Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment
- (2011) Hua Hao et al. CANCER LETTERS
- Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
- (2011) A. T. Chan et al. Cancer Prevention Research
- Intestinal Inflammation and Cancer
- (2011) Thomas A. Ullman et al. GASTROENTEROLOGY
- Regulation of inflammation in cancer by eicosanoids
- (2011) Emily R. Greene et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Emerging roles of resolvins in the resolution of inflammation and pain
- (2011) Ru-Rong Ji et al. TRENDS IN NEUROSCIENCES
- Lipoxin A4and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
- (2010) Ying Chen et al. MOLECULAR CANCER THERAPEUTICS
- Lipoxin A4inhibited hepatocyte growth factor-induced invasion of human hepatoma cells
- (2009) Xiao-Yan Zhou et al. HEPATOLOGY RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started